Prometheus Biosciences Story
RXDXDelisted Stock | USD 199.92 0.24 0.12% |
Slightly above 55% of Prometheus Biosciences' investor base is interested to short. The analysis of current outlook of investing in Prometheus Biosciences suggests that many traders are impartial regarding Prometheus Biosciences' prospects. Prometheus Biosciences' investor sentiment overview provides quick insight into current market opportunities from investing in Prometheus Biosciences. The current market sentiment, together with Prometheus Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Prometheus Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Prometheus Biosciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Prometheus daily returns and investor perception about the current price of Prometheus Biosciences as well as its diversification or hedging effects on your existing portfolios.
Prometheus |
Requested story not found. it has been either deleted or moved. View all stories for Prometheus Biosciences.
Prometheus Biosciences Latest Timeline
Prometheus Biosciences is listed for 199.92. About 17.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 3.54. Prometheus Biosciences had not issued any dividends in recent years. The entity had 1:100 split on the 1st of November 2013.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Prometheus Biosciences information on this page should be used as a complementary analysis to other Prometheus Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Prometheus Stock
If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |